Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan Paul H. SugarbakerO. Anthony Stuart Original Article 08 November 2006 Pages: 151 - 155
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells Christine MüllerDietmar GrossArmin Buschauer Original Article 16 May 2006 Pages: 157 - 164
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma Monica M. MitaEric K. RowinskyAmita Patnaik Original Article 31 May 2006 Pages: 165 - 174
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting Hongxia LuBin LiCongjian Xu Original Article 23 May 2006 Pages: 175 - 181
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma Christopher A. CarterCharles ChenXiaomei Zhang Original Article 25 May 2006 Pages: 183 - 195
An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed Claire L. Graham-ColeHuw D. ThomasAlan V. Boddy Original Article 24 May 2006 Pages: 197 - 206
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies Cynthia MaSumithra J. MandrekarAlex A. Adjei Original Article 09 June 2006 Pages: 207 - 215
Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells Jingbo LiuJing LiNeil Sidell Original Article 01 June 2006 Pages: 217 - 225
5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation Shamima IslamFerdaus HassanTakashi Yokochi Original Article 25 May 2006 Pages: 227 - 233
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity D. HenleyM. IsbillJ. Wimalasena Original Article 14 September 2006 Pages: 235 - 249
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas R. LosaJ. FraJosé M. Buesa Original Article 31 May 2006 Pages: 251 - 259
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors Bryan SchneiderAnna FukunagaChristopher Sweeney Original Article 30 May 2006 Pages: 261 - 268
Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer Jae Hong SeoSang Cheul OhBum Hwan Koo Original Article 09 June 2006 Pages: 269 - 274
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model Claudia AbramjukMichael LeinKlaus Jung Original Article 07 June 2006 Pages: 275 - 282
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin) Jung Su RyuHong Sub LeeTae Yong Kim Erratum 26 August 2006 Pages: 283 - 284